View Generic ICR - OIRA Conclusion



0910-0497 200711-0910-006
Historical Active 200603-0910-001
HHS/FDA
Focus Groups as Used by the Food and Drug Administration
Extension without change of a currently approved collection   No
Regular
Approved without change 02/05/2008
Retrieve Notice of Action (NOA) 11/20/2007
This generic clearance for FDA focus groups is approved for 3 years under the following conditions: 1) FDA shall submit memos for individual focus groups (e.g., statement of need, intended use of information, description of respondents, information collection procedures, justification for incentive, estimated burden, participant screener, and moderator guide). 2) OMB will respond with clearance or questions within 10 working days 3) OMB and FDA will jointly evaluate the generic clearance upon resubmission in 3 years. Upon resubmission, FDA will provide a summary of each collection approved under the generic clearance (e.g., use of information).
  Inventory as of this Action Requested Previously Approved
02/28/2011 36 Months From Approved 02/29/2008
2,574 0 2,574
4,252 0 4,252
0 0 0